fondaparinux sodium

Generic: fondaparinux sodium

Labeler: dr. reddy's laboratories limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name fondaparinux sodium
Generic Name fondaparinux sodium
Labeler dr. reddy's laboratories limited
Dosage Form INJECTION
Routes
SUBCUTANEOUS
Active Ingredients

fondaparinux sodium 10 mg/.8mL

Manufacturer
Dr. Reddy's Laboratories Limited

Identifiers & Regulatory

Product NDC 55111-681
Product ID 55111-681_2a3f9c6b-885b-843d-9cc8-3eb67395fbda
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA091316
Listing Expiration 2026-12-31
Marketing Start 2011-07-14

Pharmacologic Class

Classes
factor xa inhibitor [epc] factor xa inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55111681
Hyphenated Format 55111-681

Supplemental Identifiers

RxCUI
861356 861360 861363 861365
UNII
X0Q6N9USOZ

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name fondaparinux sodium (source: ndc)
Generic Name fondaparinux sodium (source: ndc)
Application Number ANDA091316 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 10 mg/.8mL
source: ndc
Packaging
  • 2 SYRINGE in 1 CARTON (55111-681-02) / .8 mL in 1 SYRINGE (55111-681-11)
  • 10 SYRINGE in 1 CARTON (55111-681-10) / .8 mL in 1 SYRINGE (55111-681-11)
source: ndc

Packages (2)

Ingredients (1)

fondaparinux sodium (10 mg/.8mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "2a3f9c6b-885b-843d-9cc8-3eb67395fbda", "openfda": {"unii": ["X0Q6N9USOZ"], "rxcui": ["861356", "861360", "861363", "861365"], "spl_set_id": ["49e0d7bc-3f49-849b-c77c-98682d1c0d19"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE in 1 CARTON (55111-681-02)  / .8 mL in 1 SYRINGE (55111-681-11)", "package_ndc": "55111-681-02", "marketing_start_date": "20110714"}, {"sample": false, "description": "10 SYRINGE in 1 CARTON (55111-681-10)  / .8 mL in 1 SYRINGE (55111-681-11)", "package_ndc": "55111-681-10", "marketing_start_date": "20110714"}], "brand_name": "Fondaparinux Sodium", "product_id": "55111-681_2a3f9c6b-885b-843d-9cc8-3eb67395fbda", "dosage_form": "INJECTION", "pharm_class": ["Factor Xa Inhibitor [EPC]", "Factor Xa Inhibitors [MoA]"], "product_ndc": "55111-681", "generic_name": "Fondaparinux Sodium", "labeler_name": "Dr. Reddy's Laboratories Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fondaparinux Sodium", "active_ingredients": [{"name": "FONDAPARINUX SODIUM", "strength": "10 mg/.8mL"}], "application_number": "ANDA091316", "marketing_category": "ANDA", "marketing_start_date": "20110714", "listing_expiration_date": "20261231"}